Download PDF
Thromb Haemost 1964; 11(02): 372-392
DOI: 10.1055/s-0038-1654835
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Induction of Increased Fibrinolytic Activator in Plasma by Various Drugs*)

M. H Cho
1   Anesthesiology Research Laboratory, State University of New York, Upstate Medical Center, Syracuse, New York
,
W Choy
1   Anesthesiology Research Laboratory, State University of New York, Upstate Medical Center, Syracuse, New York
› Author AffiliationsSupported by Grant N B-03809-02 from U.S. Public Health Service, National Institutes of Health.
Further Information

Publication History

Publication Date:
24 July 2018 (online)

Also available at
    Permissions and Reprints

Summary

Autonomic blocking agents failed to block the action of autonomic transmitters’ effect on F.A. increase in plasma. Autonomic blocking agents themselves caused the elevation of F.A. The depletion of catecholamines and serotonin, by reserpine and adrenalectomy, did not impair the ability of animals to produce enhanced F.A.level, nor did the removal of the spleen, kidney or hypophysis.

Many drugs were found to induce the increased F.A. level in plasma of animals, while others failed to do so. One common denominator of those drugs causing F.A. increase appears to be their ability to release histamine. Histamine was found to be an active agent in elevating F.A. and this action can sometimes be blocked by antihistaminics, as shown in a few experiments. The repeated injection of morphine, d-tubocurarine and compound 48/80, all showed the development of acute tolerance toward the hypotensive effect. The concomitant measurement of F.A. in plasma showed a parallel development of acute tolerance toward the F.A. level. There was a concomitant increase of histamine level, F.A. level and hematocrit value, after the single injection, each, of compound 48/80, morphine and d-tubocurarine. These results support our hypothesis that the F.A.in an animal, induced by various drugs, is caused either by histamine or a histamine release mechanism.

 

  • References

  • 1 Biggs R, MacFarlane R. G. Human Blood Coagulation and Its Disorders. 3rd Ed. 118-133 Blackwell Scientific Publications; Oxford: 1962
    Google Scholar
  • 2 Genton E, Kern F, von Kaulla K. Fibrinolysis induced by pressor amines. Amer. J. Med. 31: 564 1961;
    CrossrefPubMedGoogle Scholar
  • 3 Pohala M. J, Yen C. Y, Singher H. O. Effect of neuroactive drugs on production of fibrinolytic activity. Amer. J. Physiol. 202 (05) 984 1962;
    PubMedGoogle Scholar
  • 4 Milstone H. A factor in normal human blood which participates in streptococcal fibrinolysis. J. Immunol. 42: 109 1941;
    PubMedGoogle Scholar
  • 5 Owren P. A. The coagulation of blood. Investigation on a new clotting factor. Acta med. scand. Suppl 194: 1 1947;
    PubMedGoogle Scholar
  • 6 Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem. 40: 346 1952;
    CrossrefPubMedGoogle Scholar
  • 7 Noah J. W, Brand A. A fluorometric method to determine levels of histamine in human plasma. J. Allergy. 32: 236 1961;
    CrossrefPubMedGoogle Scholar
  • 8 Evans AGJ, Nasmyth P. A, Stewart H. G. The fall of blood pressure caused by intravenous morphine in the rat and the cat. Brit. J. Pharmacol. 07: 542 1952;
    PubMedGoogle Scholar
  • 9 Alam M, Anrep G. V, Barsoum G. S, Talaat M, Wieninger E. Liberation of histamine from the skeletal muscle by curare. J. Physiol. 95: 148 1939;
    CrossrefPubMedGoogle Scholar
  • 10 Goodman L. S, Gilman A. The Pharmacological Basis of Therapeutics. 2nd Ed. 582 MacMillan Co; N.Y: 1956
    Google Scholar
  • 11 Mayer S, Moran N. G, Fain J. The effect of adrenergic blocking agents on some metabolic actions of catecholamines. J. Pharmacol, exp. Ther. 134: 18 1961;
    PubMedGoogle Scholar
  • 12 Fearnly G. R, Ghakrabarti R, Vincent C. T. Effect of sulfoureas on fibrinolysis. Lancet. II: 622 1960;
    PubMedGoogle Scholar
  • 13 Goppola J. A, DiPalma J. R. Histamine as a factor in tolerance to levarterenol. Amer. J. Physiol. 202 (01) 114 1962;
    PubMedGoogle Scholar
  • 14 Raton WDM. Histamine release by compounds of simple chemical structure. Pharmacol. Rev. 09: 269 1957;
    PubMedGoogle Scholar
  • 15 Högberg B, Uvnäs B. Inhibitory action of allicin on degranulation of mast cell produced by compound 48/80, histamine liberator from ascaris, lecinthinase A, and antigen. Acta physiol, scand. 44: 157 1958;
    CrossrefPubMedGoogle Scholar
  • 16 Högberg B, Uvnäs B. Further observation on disruption of rat mesentery mast cells caused by compound 48/80, antigen-antibody reaction. Lecithinase A, and Decylamine. Acta physiol, scand. 48: 133 1960;
    PubMedGoogle Scholar
  • 17 Lagunojf D, Benditt E. P. Proteolytic enzymes of mast cells. Ann. N.Y. Acad. Sci. 103 (art. 1) 185 1963;
    PubMedGoogle Scholar
  • 18 Ungar G, Yamura T, Iola J. B, Kobrin S. Further studies of the role of proteases in the allergic reaction. J. exp. Med. 113: 359 1961;
    CrossrefPubMedGoogle Scholar
  • 19 Weiner M, Redisch W, Steele J. M. Occurence of fibrinolytic activity following administration of nicotinic acid. Proc. Soc. exp. Biol. (N.Y.) 98: 755 1958;
    CrossrefPubMedGoogle Scholar
  • 20 von Kaulla K. N. Intravenous protein-free pyrogen. A powerful fibrinolytic agent in man. Circulation. 17: 187 1958;
    PubMedGoogle Scholar